Carcinoma showing thymus-like differentiation (CASTLE) is an extremely rare malignant neoplasm of the thyroid that originates from ectopic thymic tissue. No sufficient evidence exists regarding the efficacy of chemotherapy for cases with distant metastases or advanced disease because of the rarity of the disease itself.
Patient:
We report a case of CASTLE with lung metastasis that showed good responses to first-line (cisplatin, doxorubicin, vincristine, and cyclophosphamide) and second-line (carboplatin and paclitaxel) chemotherapies.
Summary:
This is the first case of CASTLE reported to show a good response to two serial chemotherapies.
Conclusion:
This case suggests that CASTLE is a chemosensitive tumor and that chemotherapy should be attempted in patients with advanced or metastatic CASTLE.
Get full access to this article
View all access options for this article.
References
1.
ItoY, MiyauchiA, NakamuraY, MiyaA, KobayashiK, KakudoK. 2007. Clinicopathologic significance of intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation: a collaborative study with Member Institutes of The Japanese Society of Thyroid Surgery. Am J Clin Pathol, 127:230–236.
2.
ChanJK, RosaiJ. 1991. Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept. Human Pathol, 22:349–367.
AbeniC, OgliosiC, RotaL, BertocchiP, HuscherA, SavelliG, LombardiM, ZaniboniA. 2014. Thyroid carcinoma showing thymus-like differentiation: case presentation of a young man. World J Clin Oncol, 5:1117–1120.
5.
CappelliC, TironiA, MarchettiGP, PirolaI, De MartinoE, DelbarbaA, CastellanoM, RoseiEA. 2008. Aggressive thyroid carcinoma showing thymic-like differentiation (CASTLE): case report and review of the literature. Endocrine J, 55:685–690.
6.
ChowSM, ChanJK, TseLL, TangDL, HoCM, LawSC. 2007. Carcinoma showing thymus-like element (CASTLE) of thyroid: combined modality treatment in 3 patients with locally advanced disease. Eur J Surg Oncol, 33:83–85.
7.
KakudoK, MoriI, TamaokiN, WatanabeK. 1988. Carcinoma of possible thymic origin presenting as a thyroid mass: a new subgroup of squamous cell carcinoma of the thyroid. J Surg Oncol, 38:187–192.
8.
KusadaN, HaraY, KobayashiS, WeihuaT, NakamuraY, KakudoK, YuasaH. 2005. A case of aggressive carcinoma showing thymus-like differentiation with distant metastases. Thyroid, 15:1383–1388.
9.
HirokawaM, KumaS, MiyauchiA. 2012. Cytological findings of intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation: a study of eight cases. Diagn Cytopathol, 40(Suppl 1):E16–20.
10.
SunT, WangZ, WangJ, WuY, LiD, YingH. 2011. Outcome of radical resection and postoperative radiotherapy for thyroid carcinoma showing thymus-like differentiation. World J Surg, 35:1840–1846.
11.
YamamotoY, YamadaK, MotoiN, FujiwaraY, TodaK, SugitaniI, KohnoA. 2013. Sonographic findings in three cases of carcinoma showing thymus-like differentiation. J Clin Ultrasound, 41:574–578.
12.
LiuZ, TengXY, SunDX, XuWX, SunSL. 2013. Clinical analysis of thyroid carcinoma showing thymus-like differentiation: report of 8 cases. Int Surg, 98:95–100.
13.
AgatsumaT, KoizumiT, KandaS, ItoM, UrushihataK, YamamotoH, HanaokaM, KuboK. 2011. Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma. J Thoracic Oncol, 6:2130–2134.
14.
LemmaGL, LeeJW, AisnerSC, LangerCJ, TesterWJ, JohnsonDH, Loehrer PJSr. 2011. Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol, 29:2060–2065.
15.
HiraiF, YamanakaT, TaguchiK, DagaH, OnoA, TanakaK, KogureY, ShimizuJ, KimuraT, FukuokaJ, IwamotoY, SasakiH, TakedaK, SetoT, IchinoseY, NakagawaK, NakanishiY; West Japan Oncology Group 2015 A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L. Ann Oncol, 26:363–368.
16.
WatanabeK, ShinkaiM, GotoH, YoshikawaS, YamaguchiN, HaraY, ShinodaM, MoriyamaY, RubinBK, IshigatsuboY, KanekoT. 2013. Chemotherapy with carboplatin and paclitaxel after failure of primary chemotherapy for advanced thymic carcinoma. A report of three cases and review of the literature. Tumori, 99:e172–176.
17.
KomatsuY, KoizumiT, TanabeT, HatayamaO, YasuoM, OkadaM, YamamotoH, KuboK, SasabayashiS, TsunodaT. 2006. Salvage chemotherapy with carboplatin and paclitaxel for cisplatin-resistant thymic carcinoma—three cases. Anticancer Res, 26:1851–1856.
